Exclusives Archives - Spark Newswire

2 minute read

EXCLUSIVE: Adial Pharmaceuticals Announces Publication In Journal Supporting the Potential Efficacy Of AD04 For Alcohol Use Disorder

June 20, 8:00 AM

Adial Pharmaceuticals publishes Phase 3 ONWARD study results in the European Journal of Internal Medicine. The study reveals AD04 significantly reduces heavy drinking days, with adverse events matching the placebo.

ADIL

2 minute read

EXCLUSIVE: Will The Crypto Bulls Come Back In the Fall? Experts Explain Why Summers Are Not The Best For Bitcoin, Ethereum And Other Coins

By Aniket Verma

June 20, 7:45 AM

"Sell in May and Walk Away." This age-old Wall Street adage, in addition to the stock market, has proven increasingly applicable to cryptocurrencies as well. From June to August, market growth and trading volumes have historically trended down across the sector.

BTC

3 minute read

EXCLUSIVE: Nvidia Vs. Apple — Which Tech Giant Reigns Supreme With Retail Investors?

By Chris Katje

June 18, 4:51 PM

Benzinga followers were asked to pick which stock they preferred between Nvidia and Apple. Here's how the vote went.

AAPL

3 minute read

Not DC, But The States: Tim Seymour Discusses How Red States Could Catalyze Cannabis Growth

By Nicolas Jose Rodriguez

June 18, 11:20 AM

Tim Seymour, portfolio manager of the $CNBS Amplify Seymour Cannabis ETF (NYSE: CNBS), is a key voice in the cannabis investment community.

CRLBF

2 minute read

EXCLUSIVE: Meta’s AI, Metaverse Growth Drive Launch Of New Direxion Leveraged And Inverse ETFs

By Surbhi Jain

June 18, 8:02 AM

New ETFs from Direxion, METU and METD, provide traders with tools to capitalize on short-term movements of Meta Platforms Inc (NASDAQ:META) stock.

‘Warning Flags’: Expert Says Nvidia In ‘Bubble-ish Territory,’ Points To Potential Market Pullback

By Hayden Buckfire

June 17, 3:36 PM

Piper Sandler's Craig Johnson warns of potential market pullback in 2024 amid historic performance, advises taking profits on NVIDIA and watching less-covered stocks.

3 minute read

EXCLUSIVE: What Matters Most To Retail Investors At GameStop’s Annual Shareholders Meeting – Roaring Kitty, Crypto, Or Turnaround?

By Chris Katje

June 17, 10:10 AM

GameStop's annual shareholders meeting could include coverage of these key topics on the minds of investors.

BTC

3 minute read

Tim Seymour On Running A Cannabis Fund: ‘We Focus On Companies Poised For Growth’

By Nicolas Jose Rodriguez

June 17, 9:26 AM

Tim Seymour, portfolio manager of the $CNBS Amplify Seymour Cannabis ETF (NYSE: CNBS), is renowned for recognizing the potential of the cannabis sector early on.

BTI

2 minute read

EXCLUSIVE: Femasys At Inflection Point And Undervalued, Expects Growth Potential Following Roe v. Wade Overturn, CEO Says

By Vandana Singh

June 17, 3:22 AM

Femasys focuses on innovative women's healthcare solutions. Their FemBloc product, a non-surgical permanent birth control, is in late-stage development, aiming for a $20 billion market.

FEMY

3 minute read

EXCLUSIVE: ‘Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,’ Petros Pharma President Says

By Vandana Singh

June 17, 3:08 AM

Petros Pharmaceuticals specializes in men's health therapeutics. President Fady Boctor discusses the company's strategy to make key prescription medications. Petros is poised to expand within the $66.5 billion Rx-to-OTC market projected by 2033.

PTPI